NEW YORK, Jan. 12, 2017 /PRNewswire/ -- Cota, the leading data and technology platform for value-based precision medicine, today announced a major update to its end-to-end software solution for health care providers participating in the Center for Medicare and Medicaid Services (CMS) Oncology Care Model (OCM) payment program. The newest version of the software, recently renamed Cota OCM™, incorporates all recent changes to quality measure calculations issued recently by CMS, and debuts brand-new features enabling practices to analyze their performance by any combination of quality measure, physician, site, and patient to discover improvement opportunities.
"Participating in OCM presents massive challenges to a provider, as they lack the infrastructure and resources to comply with, much less succeed in the program," says Eric Schultz, CEO of Cota. "Cota's OCM solution automates and reduces the burden of data gathering, quality metrics calculation, and reporting, while providing actionable insights that help providers maximize their incentive payments."
Cota OCM™ is part of Cota's CNA Guided Care™ Platform, which securely ingests raw structured and unstructured patient data from any EHR platform, enriches it into research-grade data, and makes it available to analyze and visualize using a web browser. Cota OCM™ includes powerful capabilities such as automatically qualifying eligible patients and calculating all required practice-reported measures, automatically preparing and submitting data to CMS, and a new web interface for providers to optimize program performance. Cota's team of dedicated oncology-specific clinical and technical experts help guide practices through the full process from initial assessment to automated reporting and analysis, ensuring upside is maximized through the life of the program.
Beginning in 2017, by law any provider receiving reimbursements from CMS for patient care must be part of a Quality Payment Program (QPP) — a designation which includes OCM — or receive decreases in their reimbursement payments. With a significant percentage of all oncology providers receiving reimbursements, a comprehensive, software-based solution to maximize success from OCM and other QPPs is a critical necessity.
Cota is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the care of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology enriches raw medical records to create research-grade data, and joins it with a suite of analysis, visualization, and management tools. This enables providers, payers, and life sciences companies to analyze, report on, and research outcomes, costs, treatments, and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and science to help improve the lives of patients everywhere.
Media Contact: Matthew Levin
Phone: +1 (646) 543-2682
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cota-announces-new-version-of-oncology-care-model-solution-for-health-care-providers-300390635.html